Acadia Pharmaceuticals

ACAD

ACAD
Acadia Pharmaceuticals Stock Quote
$40.70 $0.84 2.1%
Price as of August 13, 2020, 10:30 a.m. EDT View Interactive ACAD Charts

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Interactive Chart


News & Analysis: Acadia Pharmaceuticals

The Fool has written over 200 articles on Acadia Pharmaceuticals.

All

Market Moves

Earnings


Is Acadia Pharmaceuticals a Buy?

A strong Q1 performance set the tone, but commitment to its strategy will be key to drive the stock higher.








2 Biotech Stocks to Watch In 2020

Acadia Pharmaceuticals and CRISPR Therapeutics both trounced the market last year. Here's why that could continue.